• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nrf2/HMGB1/TLR4/NF-κB 信号通路在狼疮肾炎中的潜在调控作用。

Potential regulatory role of the Nrf2/HMGB1/TLR4/NF-κB signaling pathway in lupus nephritis.

机构信息

Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.

Xiyuan Clinical Medical College of Beijing University of Chinese Medicine, Beijing, 100029, China.

出版信息

Pediatr Rheumatol Online J. 2023 Oct 23;21(1):130. doi: 10.1186/s12969-023-00909-5.

DOI:10.1186/s12969-023-00909-5
PMID:37872565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10594751/
Abstract

OBJECTIVES

Systemic lupus erythematosus is an autoimmune disease that involves multiple organ systems. One of its major complications, lupus nephritis (LN), is associated with a high mortality rate, and children-onset LN have a more severe course and worse prognosis than adults. Oxidative stress and inflammatory responses are involved in LN development and pathogenesis. Thus, this study aimed to explore the role of signaling regulation of the Nrf2/HMGB1/TLR/NF-κB pathway in LN pathogenesis and unravel the expression of TLR4CXCR4 plasma cells subset (PCs) in LN.

METHODS

C57BL/6 and MRL/lpr mice were divided into four groups: control, model, vector control, and Nrf2 overexpression groups. The vector control and Nrf2 overexpression groups were injected with adenoviral vectors into the kidney in situ. Pathological changes in kidney tissues were observed by hematoxylin-eosin staining. The expression of Nrf2, HMGB1, TLR4, NF-κB, and downstream inflammatory factors in kidney samples was analyzed by quantitative polymerase chain reaction, western blotting, and enzyme-linked immunosorbent assay. The ratios of TLR4CXCR4 PC subsets in the blood and kidneys of mice were determined by flow cytometry.

RESULTS

In MRL/lpr mice, Nrf2 was downregulated while HMGB1/TLR4/NF-κB pathway proteins were upregulated. Nrf2 overexpression decreased the expression of HMGB1, TLR4, NF-κB, and its downstream inflammatory cytokines (IL-1β and TNFα). These cytokines were negatively correlated with an increase in Nrf2 content. PC and TLR4  CXCR4  PCs in the blood and kidney samples were significantly increased in MRL/lpr mice; however, they were decreased upon Nrf2 overexpression.

CONCLUSION

This study showed severe kidney injury in an LN mouse model and an increased ratio of TLR4 CXCR4  PCs. Furthermore, we observed that Nrf2 regulates LN immune response through the Nrf2/HMGB1/TLR4/NF-κB pathway, which can be considered an important target for LN treatment. The clinical value of the findings of our study requires further investigation.

摘要

目的

系统性红斑狼疮是一种涉及多个器官系统的自身免疫性疾病。其主要并发症之一狼疮肾炎(LN)与高死亡率相关,且儿童发病的 LN 比成人具有更严重的病程和更差的预后。氧化应激和炎症反应参与 LN 的发生和发病机制。因此,本研究旨在探讨 Nrf2/HMGB1/TLR/NF-κB 通路信号调节在 LN 发病机制中的作用,并阐明 LN 中 TLR4CXCR4 浆细胞亚群(PCs)的表达。

方法

将 C57BL/6 和 MRL/lpr 小鼠分为四组:对照组、模型组、载体对照组和 Nrf2 过表达组。载体对照组和 Nrf2 过表达组通过原位注射腺病毒载体。通过苏木精-伊红染色观察肾组织的病理变化。通过定量聚合酶链反应、western blot 和酶联免疫吸附试验分析肾组织中 Nrf2、HMGB1、TLR4、NF-κB 及下游炎症因子的表达。通过流式细胞术测定小鼠血液和肾脏中 TLR4CXCR4 PC 亚群的比例。

结果

在 MRL/lpr 小鼠中,Nrf2 下调而 HMGB1/TLR4/NF-κB 通路蛋白上调。Nrf2 过表达降低了 HMGB1、TLR4、NF-κB 及其下游炎症细胞因子(IL-1β 和 TNFα)的表达。这些细胞因子与 Nrf2 含量的增加呈负相关。MRL/lpr 小鼠血液和肾脏样本中的 PC 和 TLR4CXCR4 PC 明显增加;然而,Nrf2 过表达后它们减少。

结论

本研究显示 LN 小鼠模型中存在严重的肾脏损伤和 TLR4CXCR4 PC 比例增加。此外,我们观察到 Nrf2 通过 Nrf2/HMGB1/TLR4/NF-κB 通路调节 LN 免疫反应,这可被视为 LN 治疗的一个重要靶点。本研究结果的临床价值需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8202/10594751/548b89a53f4c/12969_2023_909_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8202/10594751/1a408f847b46/12969_2023_909_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8202/10594751/8eae9f8c9c1b/12969_2023_909_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8202/10594751/bea2880b7e7d/12969_2023_909_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8202/10594751/90433d6db2bd/12969_2023_909_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8202/10594751/548b89a53f4c/12969_2023_909_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8202/10594751/1a408f847b46/12969_2023_909_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8202/10594751/8eae9f8c9c1b/12969_2023_909_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8202/10594751/bea2880b7e7d/12969_2023_909_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8202/10594751/90433d6db2bd/12969_2023_909_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8202/10594751/548b89a53f4c/12969_2023_909_Fig5_HTML.jpg

相似文献

1
Potential regulatory role of the Nrf2/HMGB1/TLR4/NF-κB signaling pathway in lupus nephritis.Nrf2/HMGB1/TLR4/NF-κB 信号通路在狼疮肾炎中的潜在调控作用。
Pediatr Rheumatol Online J. 2023 Oct 23;21(1):130. doi: 10.1186/s12969-023-00909-5.
2
Extracellular HMGB1 Induced Glomerular Endothelial Cell Injury via TLR4/MyD88 Signaling Pathway in Lupus Nephritis.细胞外 HMGB1 通过 TLR4/MyD88 信号通路诱导狼疮肾炎肾小球内皮细胞损伤。
Mediators Inflamm. 2021 Dec 21;2021:9993971. doi: 10.1155/2021/9993971. eCollection 2021.
3
Complement 1q protects MRL/lpr mice against lupus nephritis via inhibiting the nuclear factor-κB pathway.补体 1q 通过抑制核因子-κB 通路保护 MRL/lpr 小鼠免受狼疮肾炎的影响。
Mol Med Rep. 2020 Dec;22(6):5436-5443. doi: 10.3892/mmr.2020.11588. Epub 2020 Oct 14.
4
1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.1,25-二羟维生素 D3 通过抑制 MRL/lpr 小鼠的 NF-κB 和 MAPK 信号通路改善狼疮肾炎。
BMC Nephrol. 2022 Jul 8;23(1):243. doi: 10.1186/s12882-022-02870-z.
5
Inhibition of HMGB1 improves necrotizing enterocolitis by inhibiting NLRP3 via TLR4 and NF-κB signaling pathways.高迁移率族蛋白 B1 的抑制通过 TLR4 和 NF-κB 信号通路抑制 NLRP3 改善坏死性小肠结肠炎。
J Cell Physiol. 2019 Aug;234(8):13431-13438. doi: 10.1002/jcp.28022. Epub 2019 Jan 7.
6
Co-Delivery Of Dihydroartemisinin And HMGB1 siRNA By TAT-Modified Cationic Liposomes Through The TLR4 Signaling Pathway For Treatment Of Lupus Nephritis.通过 TLR4 信号通路介导的 TAT 修饰阳离子脂质体共递送双氢青蒿素和 HMGB1siRNA 治疗狼疮性肾炎。
Int J Nanomedicine. 2019 Nov 4;14:8627-8645. doi: 10.2147/IJN.S220754. eCollection 2019.
7
Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.淫羊藿苷通过抑制 NF-κB 激活途径和 NLRP3 炎性小体缓解狼疮肾炎。
Life Sci. 2018 Sep 1;208:26-32. doi: 10.1016/j.lfs.2018.07.009. Epub 2018 Jul 6.
8
[Effect of oxymatrine on infection in mice based on the HMGB1-TLR2/TLR4-NF-κB pathway].[基于HMGB1-TLR2/TLR4-NF-κB通路探讨氧化苦参碱对小鼠感染的影响]
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2024 Jun 17;36(3):286-293. doi: 10.16250/j.32.1374.2024019.
9
STING upregulation mediates ferroptosis and inflammatory response in lupus nephritis by upregulating and activating NF-κB signal pathway.STING 上调通过上调和激活 NF-κB 信号通路介导狼疮肾炎中的铁死亡和炎症反应。
J Biosci. 2024;49.
10
Gold-quercetin nanoparticles prevent metabolic endotoxemia-induced kidney injury by regulating TLR4/NF-κB signaling and Nrf2 pathway in high fat diet fed mice.金-槲皮素纳米颗粒通过调节高脂饮食喂养小鼠的TLR4/NF-κB信号通路和Nrf2途径来预防代谢性内毒素血症诱导的肾损伤。
Int J Nanomedicine. 2017 Jan 5;12:327-345. doi: 10.2147/IJN.S116010. eCollection 2017.

引用本文的文献

1
Unveiling the Therapeutic Potential of Dulaglutide in Mitigating Tacrolimus-Induced Nephrotoxicity Through Targeting the miR-22/HMGB-1/TLR4/MyD88/NF-κB Trajectory.揭示度拉糖肽通过靶向miR-22/HMGB-1/TLR4/MyD88/NF-κB信号通路减轻他克莫司诱导的肾毒性的治疗潜力。
Arch Pharm (Weinheim). 2025 Apr;358(4):e3127. doi: 10.1002/ardp.202500023.
2
Comparison of TLR4, NF-κB and IRF3 expression in kidney tissue between lupus nephritis (LN) and systemic lupus erythematosus (SLE): a pristane-induced lupus mice model study.狼疮性肾炎(LN)与系统性红斑狼疮(SLE)肾脏组织中TLR4、NF-κB和IRF3表达的比较:一项 pristane 诱导的狼疮小鼠模型研究
Lupus Sci Med. 2025 Apr 7;12(1):e001445. doi: 10.1136/lupus-2024-001445.
3

本文引用的文献

1
Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study.利妥昔单抗生物类似药BCD020在儿童狼疮性肾炎中显示出优于传统非生物制剂治疗的疗效:回顾性队列研究数据
Biomedicines. 2023 May 22;11(5):1503. doi: 10.3390/biomedicines11051503.
2
Belimumab for the treatment of pediatric patients with lupus nephritis.贝利尤单抗治疗狼疮性肾炎的儿科患者。
Expert Opin Biol Ther. 2023 Mar;23(3):243-251. doi: 10.1080/14712598.2023.2178297. Epub 2023 Feb 17.
3
Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study.
Preventive treatment of tripdiolide ameliorates kidney injury in diabetic mice by modulating the Nrf2/NF-κB pathway.
雷公藤甲素的预防性治疗通过调节Nrf2/NF-κB信号通路改善糖尿病小鼠的肾损伤。
Front Pharmacol. 2025 Mar 19;16:1492834. doi: 10.3389/fphar.2025.1492834. eCollection 2025.
4
Myricetin exposure reduces PC differentiation in vitro in primary human B cells.杨梅素处理可降低原代人B细胞在体外的PC分化。
Mol Med. 2025 Jan 29;31(1):28. doi: 10.1186/s10020-025-01068-x.
5
The Role of Antioxidant Transcription Factor Nrf2 and Its Activating Compounds in Systemic Lupus Erythematosus.抗氧化转录因子Nrf2及其激活化合物在系统性红斑狼疮中的作用
Antioxidants (Basel). 2024 Oct 11;13(10):1224. doi: 10.3390/antiox13101224.
6
Human and Murine Toll-like Receptor-Driven Disease in Systemic Lupus Erythematosus.人类和鼠类 Toll 样受体驱动的系统性红斑狼疮疾病。
Int J Mol Sci. 2024 May 14;25(10):5351. doi: 10.3390/ijms25105351.
系统性红斑狼疮的全球流行病学:全面系统分析和建模研究。
Ann Rheum Dis. 2023 Mar;82(3):351-356. doi: 10.1136/ard-2022-223035. Epub 2022 Oct 14.
4
Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases.靶向Nrf2治疗炎症相关疾病的小分子化合物的临床研究进展
Antioxidants (Basel). 2022 Aug 12;11(8):1564. doi: 10.3390/antiox11081564.
5
Diagnostic accuracy of the American College of Rheumatology-1997, the Systemic Lupus International Collaborating Clinics-2012, and the European League Against Rheumatism-2019 criteria for juvenile systemic lupus erythematosus: A systematic review and network meta-analysis.美国风湿病学会 1997 年、系统性红斑狼疮国际协作组 2012 年和欧洲抗风湿病联盟 2019 年青少年系统性红斑狼疮诊断标准的诊断准确性:系统评价和网络荟萃分析。
Autoimmun Rev. 2022 Sep;21(9):103144. doi: 10.1016/j.autrev.2022.103144. Epub 2022 Jul 13.
6
Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway.KEAP1-NRF2-ARE 抗氧化反应通路中的信号放大。
Redox Biol. 2022 Aug;54:102389. doi: 10.1016/j.redox.2022.102389. Epub 2022 Jun 30.
7
Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis - A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria.努力制定青少年增殖性狼疮性肾炎的达标治疗方案——德国和奥地利儿科风湿病学家和肾病学家的一项调查
Front Pediatr. 2022 Apr 22;10:851998. doi: 10.3389/fped.2022.851998. eCollection 2022.
8
Recent Advances in Understanding Nrf2 Agonism and Its Potential Clinical Application to Metabolic and Inflammatory Diseases.理解 Nrf2 激动剂的最新进展及其在代谢和炎症性疾病中的潜在临床应用。
Int J Mol Sci. 2022 Mar 5;23(5):2846. doi: 10.3390/ijms23052846.
9
The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus.Nrf2激活作为系统性红斑狼疮治疗靶点的潜力
Metabolites. 2022 Feb 6;12(2):151. doi: 10.3390/metabo12020151.
10
Extracellular HMGB1 Induced Glomerular Endothelial Cell Injury via TLR4/MyD88 Signaling Pathway in Lupus Nephritis.细胞外 HMGB1 通过 TLR4/MyD88 信号通路诱导狼疮肾炎肾小球内皮细胞损伤。
Mediators Inflamm. 2021 Dec 21;2021:9993971. doi: 10.1155/2021/9993971. eCollection 2021.